एपीए उद्धरण

Nakano, K., Hayakawa, K., Funauchi, Y., Tanizawa, T., Ae, K., Matsumoto, S., . . . Takahashi, S. (2021). Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line. Mol Clin Oncol.

शिकागो स्टाइल उद्धरण

Nakano, Kenji, et al. "Differences in the Efficacy and Safety of Eribulin in Patients With Soft Tissue Sarcoma By Histological Subtype and Treatment Line." Mol Clin Oncol 2021.

एमएलए उद्धरण

Nakano, Kenji, et al. "Differences in the Efficacy and Safety of Eribulin in Patients With Soft Tissue Sarcoma By Histological Subtype and Treatment Line." Mol Clin Oncol 2021.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.